iShares STOXX Europe Large 200 UCITS ETF (DE)
EXSC.DE
Deutsche Börse- -
EUR
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- iShares STOXX Europe Large 200 UCITS ETF (DE) (EXSC.DE) is an exchange-traded fund that seeks to track the performance of the STOXX Europe Large 200 Index, comprising the largest 200 companies from the broader STOXX Europe 600 Index across developed European markets. The ETF employs full physical replication, investing directly in the underlying equities; distributes dividends at least annually with a recent trailing yield of approximately 2.48%; and maintains assets under management of around EUR 119 million as of late 2025. Key holdings include leading firms such as ASML Holding NV, Roche Holding AG, AstraZeneca PLC, HSBC Holdings PLC, and Novartis AG, with significant sector allocations to financials (around 24.5%), industrials (18.4%), and health care (15.1%). The fund targets institutional and retail investors seeking broad exposure to large-cap European equities; operates without currency hedging; and lists primarily on Xetra in euros, with availability in markets including Germany, France, Italy, Austria, and the Netherlands. Issued and managed by BlackRock Asset Management Deutschland AG, a subsidiary of BlackRock Inc., the ETF carries a total expense ratio of 0.20% to 0.21% and is domiciled in Germany. Launched on April 4, 2005, and headquartered in Munich, Germany, the fund has delivered annualized returns of approximately 6.86% since inception through September 2025, reflecting its benchmark's focus on blue-chip European stocks. No major acquisitions, funding rounds, name changes, or strategic reorganizations have been reported for the ETF in the last 1-2 years; it continues standard operations amid BlackRock's broader iShares expansions in unrelated products like defense and fixed-income ETFs.